Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation

References

• LundgrenJDBabikerAEl SadrWMInferior clinical outcome of the CD4+ cell count-guided antiretroviral interruption strategy in the SMART study: role of CD4+ cell counts and HIV-RNA levels during follow-upJ Infect Dis20081971145115518476293
   PubMed Web of Science ®Google Scholar
• The Antiretroviral Therapy Cohort CollaborationLife expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesLancet200837229329918657708
   PubMed Web of Science ®Google Scholar
• VolberdingPADeeksSGAntiretroviral therapy and management of HIV infectionLancet2010376496220609987
   PubMed Web of Science ®Google Scholar
• Panel on Antiretroviral Guidelines for Adults and AdolescentsGuidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescentsDepartment of Health and Human Services Available from: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdfAccessed November 27, 2014
   Google Scholar
• ThompsonMAAbergJAHoyJFAntiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panelJAMA201230838740222820792
   PubMed Web of Science ®Google Scholar
• AntinoriAMarcotullioSAmmassariAItalian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected personsNew Microbiol20113410914621617825
   PubMed Web of Science ®Google Scholar
• MaltezFDoronaMBrancoTRecent advances in antiretroviral treatment and prevention in HIV-infected patientsCurr Opin HIV AIDS20116Suppl 1S21S3022156776
   PubMedGoogle Scholar
• CohenMSChenYQMcCauleyMHPTN 052 Study TeamPrevention of HIV-1 infection with early antiretroviral therapyN Engl J Med201136549350521767103
   PubMed Web of Science ®Google Scholar
• AiroldiMZaccarelliMBisiLOne-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjectsPatient Prefer Adherence2010411512520517472
   PubMed Web of Science ®Google Scholar
• ColomboGLDi MatteoSAntinoriAMedagliaMMurachelliSRizzardiniGEconomic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelinesClinicoecon Outcomes Res2013548949624124383
   PubMedGoogle Scholar
• SimpsonKNLuoMPChumneyECost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV irtfectionHIV Clin Trials2004529430415562370
   PubMed Web of Science ®Google Scholar
• MontanerJSLimaVDBarriosRExpanded HAART coverage is associated with decreased population-level HIV-1-RNA and annual new HIV diagnoses in British Columbia, CanadaLancet201037653253920638713
   PubMed Web of Science ®Google Scholar
• Oliva-MorenoJLopez-BatidaJSerrano-AguilarPPerestelo-PerezLDeterminants of health care costs of HIV-positive patients in the Canary Islands, SpainEur J Health Econ20101140541220049503
   PubMed Web of Science ®Google Scholar
• LevyAJohnstonKAnnemansLTramarinAMontanerJThe impact of disease stage on direct medical costs of HIV management: a review of the international literaturePharmacoeconomics201028Suppl 1354721182342
   PubMed Web of Science ®Google Scholar
• ParientiJJBangsbergDRVerdonRGardnerEMBetter adherence with once-daily antiretroviral regimens: a meta-analysisClin Infect Dis20094848448819140758
   PubMed Web of Science ®Google Scholar
• NachegaJBMugaveroMJZeierMVitóriaMGallantJETreatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costsPatient Prefer Adherence2011535736721845035
   PubMed Web of Science ®Google Scholar
• MaggioloFRipamontiDAriciCSimpler regimens may enhance adherence to antiretrovirals in HIV infected patientsHIV Clin Trials2002537137812407486
   PubMedGoogle Scholar
• LimaVDHarriganRBangsbergDRThe combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over timeJ Acquir Immune Defic Syndr20095052953619223785
   PubMed Web of Science ®Google Scholar
• SterrantinoGSantoroLBartolozziDSelf-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART eraPatient Prefer Adherence2012642743322723727
   PubMed Web of Science ®Google Scholar
• MaggioloFRavasioLRipamontiDSimilar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitorsClin Infect Dis20054015816315614706
   PubMed Web of Science ®Google Scholar
• DeschampsAEDe GraeveVVan WijngaerdenEPrevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using medication event monitoring systemAIDS Patient Care STDs20041864465715633262
   PubMed Web of Science ®Google Scholar
• BaeJWGuyerWGrimmKAlticeFLMedication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical care and researchAIDS20112527929021239892
   PubMed Web of Science ®Google Scholar
• WilligJHAbromsSWestfallAOIncreased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapyAIDS2008221951196018784459
   PubMed Web of Science ®Google Scholar
• ColomboGLDi MatteoSMaggioloFAntiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of single tablet regimenClinicoecon Outcomes Res20135596823430273
   PubMedGoogle Scholar
• RizzardiniGRestelliUBonfantiPCost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhileClinicoecon Outcomes Res2012424525222973114
   PubMedGoogle Scholar
• GanguliAWangJGourleyDRDoes combining antiretroviral agents in a single dosage form enhance quality of life of HIV/AIDS patients? A cost-utility studyRes Social Adm Pharm2012815716521712147
   PubMed Web of Science ®Google Scholar
• GrosseSDAssessing cost-effectiveness in healthcare: history of the $50,000 per QALY thresholdExpert Rev Pharmacoecon Outcomes Res2008816517820528406
   PubMedGoogle Scholar
• ColomboGLCastagnaADi MatteoSCost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital settingTher Clin Risk Manag20141091524379676
   PubMed Web of Science ®Google Scholar
• RizzardiniGBonfantiPCarenziLCost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern ItalyTher Clin Risk Manag2012837738423028230
   PubMed Web of Science ®Google Scholar